Exchange of views on rare diseases in the context of the pharmaceutical strategy for Europe and the presentation of EURORDIS Recommendations of the Foresight Study on rare diseases policy (Lobbyradar DE, 2026)
Daten unter CC-BY-SA 4.0; Quellen siehe Detailseite.